NASDAQ:QLGN
Delisted

Qualigen Therapeutics Stock Predictions

etoro logo Buy QLGN
*Your capital is at risk
$3.21
+0 (+0%)
At Close: Feb 17, 2026
Currently predicting for Fri, 5 Jun 2026

QLGN Prediction Chart

QLGN Predictions History

Latest community submissions for QLGN.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 31, 2025 $3.71 -2.44% $3.64 V 98.15% 1
Mar 31, 2025 $3.74 -1.52% $3.64 V 97.19% 1
Mar 31, 2025 $3.80 +0.00% $3.64 V 95.60% 1
Feb 24, 2025 $3.65 +2.89% $3.37 X 91.62% 0
Feb 24, 2025 $3.48 -1.90% $3.37 V 96.66% 1
Feb 24, 2025 $4.72 +32.96% $3.37 X 59.94% 0
Jul 17, 2024 $0.314 -98.11% $0.310 V 98.73% 2
Jul 17, 2024 $0.520 -96.87% $0.310 X 32.31% 0
Jul 8, 2024 $0.261 -98.14% $0.280 V 93.21% 1
Jul 8, 2024 $0.268 -98.09% $0.280 V 95.77% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for QLGN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT QUALIGEN THERAPEUTICS INC.
Qualigen Therapeutics
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that block...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE